久光製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/29 | 4,211 | 4,234 | 4,196 | 4,217 | +6 | +0.1% | 80,300 |
| 2024/01/26 | 4,193 | 4,240 | 4,191 | 4,211 | +13 | +0.3% | 111,600 |
| 2024/01/25 | 4,190 | 4,213 | 4,161 | 4,198 | -13 | -0.3% | 90,600 |
| 2024/01/24 | 4,201 | 4,228 | 4,167 | 4,211 | +10 | +0.2% | 155,200 |
| 2024/01/23 | 4,217 | 4,260 | 4,181 | 4,201 | -20 | -0.5% | 153,200 |
| 2024/01/22 | 4,147 | 4,225 | 4,125 | 4,221 | +46 | +1.1% | 214,800 |
| 2024/01/19 | 4,250 | 4,262 | 4,147 | 4,175 | -91 | -2.1% | 307,700 |
| 2024/01/18 | 4,301 | 4,325 | 4,266 | 4,266 | -105 | -2.4% | 223,200 |
| 2024/01/17 | 4,365 | 4,450 | 4,360 | 4,371 | -2 | ±0% | 203,900 |
| 2024/01/16 | 4,472 | 4,480 | 4,363 | 4,373 | -107 | -2.4% | 215,500 |
| 2024/01/15 | 4,468 | 4,506 | 4,415 | 4,480 | +34 | +0.8% | 197,700 |
| 2024/01/12 | 4,563 | 4,593 | 4,383 | 4,446 | -116 | -2.5% | 711,000 |
| 2024/01/11 | 4,566 | 4,590 | 4,513 | 4,562 | +56 | +1.2% | 239,600 |
| 2024/01/10 | 4,435 | 4,525 | 4,426 | 4,506 | +104 | +2.4% | 283,000 |
| 2024/01/09 | 4,404 | 4,409 | 4,367 | 4,402 | +49 | +1.1% | 131,100 |
| 2024/01/05 | 4,453 | 4,453 | 4,343 | 4,353 | -60 | -1.4% | 164,000 |
| 2024/01/04 | 4,330 | 4,415 | 4,282 | 4,413 | +102 | +2.4% | 78,100 |
| 2023/12/29 | 4,335 | 4,360 | 4,279 | 4,311 | -24 | -0.6% | 124,000 |
| 2023/12/28 | 4,313 | 4,364 | 4,313 | 4,335 | -2 | ±0% | 76,400 |
| 2023/12/27 | 4,273 | 4,346 | 4,257 | 4,337 | +53 | +1.2% | 124,100 |
| 2023/12/26 | 4,283 | 4,323 | 4,263 | 4,284 | -35 | -0.8% | 116,000 |
| 2023/12/25 | 4,324 | 4,342 | 4,290 | 4,319 | +23 | +0.5% | 134,000 |
| 2023/12/22 | 4,247 | 4,300 | 4,246 | 4,296 | +49 | +1.2% | 141,400 |
| 2023/12/21 | 4,274 | 4,297 | 4,231 | 4,247 | -34 | -0.8% | 152,100 |
| 2023/12/20 | 4,360 | 4,385 | 4,281 | 4,281 | -82 | -1.9% | 209,500 |
| 2023/12/19 | 4,404 | 4,422 | 4,341 | 4,363 | -48 | -1.1% | 148,100 |
| 2023/12/18 | 4,408 | 4,436 | 4,375 | 4,411 | -56 | -1.3% | 151,700 |
| 2023/12/15 | 4,530 | 4,536 | 4,454 | 4,467 | -97 | -2.1% | 210,600 |
| 2023/12/14 | 4,595 | 4,614 | 4,534 | 4,564 | -16 | -0.3% | 99,600 |
| 2023/12/13 | 4,600 | 4,622 | 4,574 | 4,580 | -11 | -0.2% | 109,700 |
| 2023/12/12 | 4,607 | 4,648 | 4,591 | 4,591 | -7 | -0.2% | 122,900 |
| 2023/12/11 | 4,610 | 4,618 | 4,549 | 4,598 | +4 | +0.1% | 143,800 |
| 2023/12/08 | 4,590 | 4,618 | 4,577 | 4,594 | -6 | -0.1% | 153,400 |
| 2023/12/07 | 4,591 | 4,645 | 4,587 | 4,600 | -50 | -1.1% | 134,800 |
| 2023/12/06 | 4,607 | 4,657 | 4,607 | 4,650 | +43 | +0.9% | 114,600 |
| 2023/12/05 | 4,580 | 4,632 | 4,580 | 4,607 | +2 | ±0% | 121,700 |
| 2023/12/04 | 4,632 | 4,639 | 4,552 | 4,605 | -47 | -1% | 109,800 |
| 2023/12/01 | 4,658 | 4,700 | 4,643 | 4,652 | +34 | +0.7% | 143,700 |
| 2023/11/30 | 4,575 | 4,647 | 4,525 | 4,618 | -2 | ±0% | 149,100 |
| 2023/11/29 | 4,621 | 4,634 | 4,551 | 4,620 | -1 | ±0% | 88,600 |
| 2023/11/28 | 4,569 | 4,621 | 4,555 | 4,621 | +53 | +1.2% | 73,400 |
| 2023/11/27 | 4,585 | 4,612 | 4,530 | 4,568 | +7 | +0.2% | 91,000 |
| 2023/11/24 | 4,607 | 4,613 | 4,539 | 4,561 | -30 | -0.7% | 64,200 |
| 2023/11/22 | 4,570 | 4,628 | 4,565 | 4,591 | +28 | +0.6% | 72,600 |
| 2023/11/21 | 4,541 | 4,586 | 4,497 | 4,563 | +23 | +0.5% | 100,200 |
| 2023/11/20 | 4,583 | 4,597 | 4,528 | 4,540 | -55 | -1.2% | 111,800 |
| 2023/11/17 | 4,457 | 4,595 | 4,457 | 4,595 | +128 | +2.9% | 126,400 |
| 2023/11/16 | 4,560 | 4,575 | 4,467 | 4,467 | -121 | -2.6% | 120,000 |
| 2023/11/15 | 4,597 | 4,643 | 4,560 | 4,588 | ±0 | ±0% | 173,600 |
| 2023/11/14 | 4,659 | 4,680 | 4,587 | 4,588 | -68 | -1.5% | 143,300 |
351～
400
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 久光薬 | 400,600円 | +5.8% | +1.2% | 3.00% | 13.29倍 | 1.06倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ロート | 205,500円 | +8.4% | +0.2% | 2.04% | 14.93倍 | 1.79倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 89,800円 | -11.0% | +206.6% | 0.00% | 8.92倍 | 2.11倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 350,500円 | +3.8% | -19.9% | 3.88% | 11.39倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 313,200円 | +8.0% | -15.3% | 3.96% | 8.79倍 | 0.86倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム
